Page last updated: 2024-10-20

phosphorylethanolamine and Infant, Premature, Diseases

phosphorylethanolamine has been researched along with Infant, Premature, Diseases in 1 studies

phosphorylethanolamine: RN given refers to parent cpd; structure
O-phosphoethanolamine : The ethanolamine mono-ester of phosphoric acid, and a metabolite of phospholipid metabolism. This phosphomonoester shows strong structural similarity to the inhibitory neurotransmitter GABA, and is decreased in post-mortem Alzheimer's disease brain.

Infant, Premature, Diseases: Diseases that occur in PREMATURE INFANTS.

Research Excerpts

ExcerptRelevanceReference
"Hypophosphatasia is a rare genetic disease characterized by deficiency of tissue-nonspecific alkaline phosphatase (TNSALP) activity, excessive urinary excretion of phosphoethanolamine, poor bone mineralization and skeletal anomalies."1.33Neonatal hypophosphatasia and seizures. A case report. ( Meli, C; Palazzo, P; Romeo, DM; Smilari, P; Sorge, G, 2005)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Smilari, P1
Romeo, DM1
Palazzo, P1
Meli, C1
Sorge, G1

Other Studies

1 other study available for phosphorylethanolamine and Infant, Premature, Diseases

ArticleYear
Neonatal hypophosphatasia and seizures. A case report.
    Minerva pediatrica, 2005, Volume: 57, Issue:5

    Topics: Chromatography, Ion Exchange; Ethanolamines; Humans; Hypophosphatasia; Infant; Infant, Newborn; Infa

2005